BECLAZONE inhalatsiooniaerosool, lahus Eesti - eesti - Ravimiamet

beclazone inhalatsiooniaerosool, lahus

norton (waterford) limited t/a ivax pharmaceuticals ireland - beklometasoon - inhalatsiooniaerosool, lahus - 250mcg 1annus 200annus 1tk

Quofenix Euroopa Liit - eesti - EMA (European Medicines Agency)

quofenix

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - Ühenduse omandatud infektsioonid - antibacterials süsteemseks kasutamiseks, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 ja 5. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.

MEDOFLOXINE 200 MG õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

medofloxine 200 mg õhukese polümeerikattega tablett

medochemie limited - ofloksatsiin - õhukese polümeerikattega tablett - 200mg 10tk; 200mg 100tk

LABELLA tablett Eesti - eesti - Ravimiamet

labella tablett

exeltis baltics uab - levonorgestreel - tablett - 1,5mg 1tk

Libmeldy Euroopa Liit - eesti - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - muud närvisüsteemi ravimid - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.